Cargando…
3D printing of pharmaceuticals for disease treatment
Three-dimensional (3D) printing or Additive manufacturing has paved the way for developing and manufacturing pharmaceuticals in a personalized manner for patients with high volume and rare diseases. The traditional pharmaceutical manufacturing process involves the utilization of various excipients t...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871616/ https://www.ncbi.nlm.nih.gov/pubmed/36704231 http://dx.doi.org/10.3389/fmedt.2022.1040052 |
_version_ | 1784877216339853312 |
---|---|
author | Chakka, L. R. Jaidev Chede, Shanthi |
author_facet | Chakka, L. R. Jaidev Chede, Shanthi |
author_sort | Chakka, L. R. Jaidev |
collection | PubMed |
description | Three-dimensional (3D) printing or Additive manufacturing has paved the way for developing and manufacturing pharmaceuticals in a personalized manner for patients with high volume and rare diseases. The traditional pharmaceutical manufacturing process involves the utilization of various excipients to facilitate the stages of blending, mixing, pressing, releasing, and packaging. In some cases, these excipients cause serious side effects to the patients. The 3D printing of pharmaceutical manufacturing avoids the need for excessive excipients. The two major components of a 3D printed tablet or dosage form are polymer matrix and drug component alone. Hence the usage of the 3D printed dosage forms for disease treatment will avoid unwanted side effects and provide higher therapeutic efficacy. With respect to the benefits of the 3D printed pharmaceuticals, the present review was constructed by discussing the role of 3D printing in producing formulations of various dosage forms such as fast and slow releasing, buccal delivery, and localized delivery. The dosage forms are polymeric tablets, nanoparticles, scaffolds, and films employed for treating different diseases. |
format | Online Article Text |
id | pubmed-9871616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98716162023-01-25 3D printing of pharmaceuticals for disease treatment Chakka, L. R. Jaidev Chede, Shanthi Front Med Technol Medical Technology Three-dimensional (3D) printing or Additive manufacturing has paved the way for developing and manufacturing pharmaceuticals in a personalized manner for patients with high volume and rare diseases. The traditional pharmaceutical manufacturing process involves the utilization of various excipients to facilitate the stages of blending, mixing, pressing, releasing, and packaging. In some cases, these excipients cause serious side effects to the patients. The 3D printing of pharmaceutical manufacturing avoids the need for excessive excipients. The two major components of a 3D printed tablet or dosage form are polymer matrix and drug component alone. Hence the usage of the 3D printed dosage forms for disease treatment will avoid unwanted side effects and provide higher therapeutic efficacy. With respect to the benefits of the 3D printed pharmaceuticals, the present review was constructed by discussing the role of 3D printing in producing formulations of various dosage forms such as fast and slow releasing, buccal delivery, and localized delivery. The dosage forms are polymeric tablets, nanoparticles, scaffolds, and films employed for treating different diseases. Frontiers Media S.A. 2023-01-10 /pmc/articles/PMC9871616/ /pubmed/36704231 http://dx.doi.org/10.3389/fmedt.2022.1040052 Text en © 2023 Chakka and Chede. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medical Technology Chakka, L. R. Jaidev Chede, Shanthi 3D printing of pharmaceuticals for disease treatment |
title | 3D printing of pharmaceuticals for disease treatment |
title_full | 3D printing of pharmaceuticals for disease treatment |
title_fullStr | 3D printing of pharmaceuticals for disease treatment |
title_full_unstemmed | 3D printing of pharmaceuticals for disease treatment |
title_short | 3D printing of pharmaceuticals for disease treatment |
title_sort | 3d printing of pharmaceuticals for disease treatment |
topic | Medical Technology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871616/ https://www.ncbi.nlm.nih.gov/pubmed/36704231 http://dx.doi.org/10.3389/fmedt.2022.1040052 |
work_keys_str_mv | AT chakkalrjaidev 3dprintingofpharmaceuticalsfordiseasetreatment AT chedeshanthi 3dprintingofpharmaceuticalsfordiseasetreatment |